Works matching IS 03682811 AND DT 2018 AND VI 48 AND IP 10


Results: 14
    1
    2
    3

    IN THIS ISSUE.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 10, p. 1, doi. 10.1093/jjco/hyy140
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 10, p. 950, doi. 10.1093/jjco/hyy114
    By:
    • Hashimoto, Hironobu;
    • Abe, Masakazu;
    • Yanai, Takako;
    • Yamaguchi, Takuhiro;
    • Zenda, Sadamoto;
    • Uchitomi, Yosuke;
    • Fukuda, Haruhiko;
    • Mori, Mikio;
    • Iwasa, Satoru;
    • Yamamoto, Noboru
    Publication type:
    Article
    11
    12
    13
    14